The Latest at the Parker Institute
The Parker Institute for Cancer Immunotherapy enables real collaboration, accelerating ambitious research to deliver new immunotherapies engineered to save lives.
World-renowned experts from leading cancer centers are at the forefront of our research.
Open in Twitter
Parker Institute
@parkerici
New article @ScienceMagazine by PICI CEO and President Jeff Bluestone (@kickassscience1): Regulatory T cells and wh… https://t.co/bxJMiicOgW
22 hours ago
Parker Institute
@parkerici
New article @ScienceMagazine by PICI CEO and President Jeff Bluestone (@kickassscience1): Regulatory T cells and wh… https://t.co/bxJMiicOgW
22 hours ago
Open in Twitter
Parker Institute
@parkerici
New data on the IO industry published by @CancerResearch in @NatRevDrugDisc evaluates trends in the global landscap… https://t.co/amNF79cOYd
22 hours ago
Parker Institute
@parkerici
New data on the IO industry published by @CancerResearch in @NatRevDrugDisc evaluates trends in the global landscap… https://t.co/amNF79cOYd
22 hours ago
Open in Twitter
Parker Institute
@parkerici
.@TIME recognizes Sean Parker @sparker as the connector for cancer research acceleration in their list of 50 influe… https://t.co/MnOEZjLNB3
24 hours ago
Parker Institute
@parkerici
.@TIME recognizes Sean Parker @sparker as the connector for cancer research acceleration in their list of 50 influe… https://t.co/MnOEZjLNB3
24 hours ago